In this study we used a C.elegans model to examine the toxicity of a rare mutation in the MAPT gene (A152TMAPT) that was recently discovered as a risk factor for frontotemporal dementia spectrum disorders (FTD, PSP, CBD, AD, and others) [51]. This evidence concerns the gene MAPT and Alzheimer disease.